View ValuationTanke Biosciences 将来の成長Future 基準チェック /06現在、 Tanke Biosciencesの成長と収益を予測するのに十分なアナリストの調査がありません。主要情報n/a収益成長率n/aEPS成長率Commercial Services 収益成長13.5%収益成長率n/a将来の株主資本利益率n/aアナリストカバレッジNone最終更新日n/a今後の成長に関する最新情報更新なしすべての更新を表示Recent updatesお知らせ • Apr 08Tanke Biosciences Corp Announces the Appointment of John P. Hopkins as Executive Chairman of the Board of Directors, Effective March 31St, 2025Tanke Biosciences Corp. announced that John P. Hopkins has been appointed Executive Chairman of the Company’s Board of Directors, effective March 31st, 2025. Mr. Hopkins has 40 years of experience in senior accounting, finance and operations, business turnarounds and M&A. Most recently, Mr. Hopkins served as the President and Chief Executive Officer of Professional Security Broadband Inc., where he was responsible for organically quadrupling revenue prior to being acquired by a private equity firm. John’s first public CFO appointment was at Measurement Specialties, a NASDAQ company, that is a leading global designer and manufacturer of sensors and sensor-based systems. Joining during a critical SEC investigation, he successfully led the financial restructuring efforts, returning the company to profitability and laying the groundwork for an eventual sale of the company for $1.7b (including assumption of net debt). After Measurement Specialties, Mr. Hopkins joined Henry Bros. Electronics, a NASDAQ company, as CFO where he was instrumental in a financial and operational turnaround, increasing the market cap by 130% prior to being acquired. Mr. Hopkins is a certified public accountant and holds an MBA from Villanova University and a bachelor’s degree in accounting from West Chester University. John volunteers teaching eighth graders as part of the Junior Achievement in the West Kensington section of Philadelphia. John also remains engaged competitively in rowing crew on boathouse row in Philadelphia.お知らせ • Feb 13Tanke Biosciences Corp Appoints Vincent Renz as Chief Executive OfficerTanke Biosciences Corp. announced that Vincent Renz has been appointed Chief Executive Officer, effective February 9, 2025. Mr. Renz has over 30 years of leadership experience at C-Suite level, having served as CTO of eResearch Technology, CEO/COO of NewCardio, Inc, COO of Clinphone, Sr. Vice President, Client Services of Computron Software. Mr. Renz has served most recently as the President and Founder of Straight4ward Advisory Services. He is experienced with driving significant value creation for shareholders and delivering on both turnaround and growth strategies. In 2024, Renz joined Brand Craft Holdings in an advisory capacity to begin building the team to identify investment opportunities. Mr. Renz began his career with positions at Anderson Consulting and Deloitte focused on development and implementation of advanced technology solutions. He holds a BBA in Finance from the University of Notre Dame, as well as an MBA with a specialization in Information Technology from the Kelley School of Business at Indiana University.お知らせ • Feb 12Tanke Biosciences Corp Announces Vincent Renz Joins its Board of DirectorsTanke Biosciences Corp. announced that Vincent Renz will join the Board of Directors, effective February 9, 2025. Mr. Renz has over 30 years of leadership experience at C-Suite level, having served as CTO of eResearch Technology, CEO/COO of NewCardio, Inc, COO of Clinphone, Sr. Vice President, Client Services of Computron Software. Mr. Renz has served most recently as the President and Founder of Straight4ward Advisory Services. He is experienced with driving significant value creation for shareholders and delivering on both turnaround and growth strategies. In 2024, Renz joined Brand Craft Holdings in an advisory capacity to begin building the team to identify investment opportunities. Mr. Renz began his career with positions at Anderson Consulting and Deloitte focused on development and implementation of advanced technology solutions. He holds a BBA in Finance from the University of Notre Dame, as well as an MBA with a specialization in Information Technology from the Kelley School of Business at Indiana University.お知らせ • Feb 28Tanke Biosciences Corp Appoints Kenneth Marks to the Board of DirectorsTanke Biosciences Corp. d.b.a BrandCraft Holdings, LLC announced that Kenneth Marks has joined the board of directors. Mr. Marks has a strong record of accomplishment as a senior executive with a proven track record, providing excellent operating, financial and corporate development leadership in U.S. domestic and global markets. Mr. Marks has held senior level positions at Verizon Communications, Global Directory Services Company and Nynex Corporation as well as within the financial industry. At Verizon, Ken held the position of Vice President for Merger Integration following the merger between Bell Atlantic and GTE. Prior to Verizon, he was President and CEO of Global Directory Services Company, a Bell Atlantic and R.R.Donnelley &Sons joint venture. Ken managed the growth of the information services company from its inception to over $575 million in annual revenue and 2000 employees, operating from offices in Europe, Asia and North America. Ken Marks has worked with several private equity firms as a Senior Advisor, including, Fulcrum Funds, LLC and LKM Ventures, LLC. Responsibilities included sourcing of capital, evaluating business opportunities and directing due diligence activities. このセクションでは通常、投資家が会社の利益創出能力を理解する一助となるよう、プロのアナリストのコンセンサス予想に基づく収益と利益の成長予測を提示する。しかし、Tanke Biosciences は十分な過去のデータを提供しておらず、アナリストの予測もないため、過去のデータを外挿したり、アナリストの予測を使用しても、その将来の収益を確実に算出することはできません。 シンプリー・ウォール・ストリートがカバーする企業の97%は過去の財務データを持っているため、これはかなり稀な状況です。 業績と収益の成長予測OTCPK:TNBI - アナリストの将来予測と過去の財務データ ( )USD Millions日付収益収益フリー・キャッシュフロー営業活動によるキャッシュ平均アナリスト数12/31/2022N/A000N/Aアナリストによる今後の成長予測収入対貯蓄率: TNBIの予測収益成長が 貯蓄率 ( 3.5% ) を上回っているかどうかを判断するにはデータが不十分です。収益対市場: TNBIの収益がUS市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です高成長収益: TNBIの収益が今後 3 年間で 大幅に 増加すると予想されるかどうかを判断するにはデータが不十分です。収益対市場: TNBIの収益がUS市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。高い収益成長: TNBIの収益が年間20%よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。一株当たり利益成長率予想将来の株主資本利益率将来のROE: TNBIの 自己資本利益率 が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です成長企業の発掘7D1Y7D1Y7D1YCommercial-services 業界の高成長企業。View Past Performance企業分析と財務データの現状データ最終更新日（UTC時間）企業分析2026/06/08 14:54終値2026/05/08 00:00収益2022/12/31年間収益2022/12/31データソース企業分析に使用したデータはS&P Global Market Intelligence LLC のものです。本レポートを作成するための分析モデルでは、以下のデータを使用しています。データは正規化されているため、ソースが利用可能になるまでに時間がかかる場合があります。パッケージデータタイムフレーム米国ソース例会社財務10年損益計算書キャッシュ・フロー計算書貸借対照表SECフォーム10-KSECフォーム10-Qアナリストのコンセンサス予想+プラス3年予想財務アナリストの目標株価アナリストリサーチレポートBlue Matrix市場価格30年株価配当、分割、措置ICEマーケットデータSECフォームS-1所有権10年トップ株主インサイダー取引SECフォーム4SECフォーム13Dマネジメント10年リーダーシップ・チーム取締役会SECフォーム10-KSECフォームDEF 14A主な進展10年会社からのお知らせSECフォーム8-K* 米国証券を対象とした例であり、非米国証券については、同等の規制書式および情報源を使用。特に断りのない限り、すべての財務データは1年ごとの期間に基づいていますが、四半期ごとに更新されます。これは、TTM（Trailing Twelve Month）またはLTM（Last Twelve Month）データとして知られています。詳細はこちら。分析モデルとスノーフレーク本レポートを生成するために使用した分析モデルの詳細は当社のGithubページでご覧いただけます。また、レポートの使用方法に関するガイドやYoutubeのチュートリアルも掲載しています。シンプリー・ウォールストリート分析モデルを設計・構築した世界トップクラスのチームについてご紹介します。業界およびセクターの指標私たちの業界とセクションの指標は、Simply Wall Stによって6時間ごとに計算されます。アナリスト筋Tanke Biosciences Corporation 0 これらのアナリストのうち、弊社レポートのインプットとして使用した売上高または利益の予想を提出したのは、 。アナリストの投稿は一日中更新されます。0
お知らせ • Apr 08Tanke Biosciences Corp Announces the Appointment of John P. Hopkins as Executive Chairman of the Board of Directors, Effective March 31St, 2025Tanke Biosciences Corp. announced that John P. Hopkins has been appointed Executive Chairman of the Company’s Board of Directors, effective March 31st, 2025. Mr. Hopkins has 40 years of experience in senior accounting, finance and operations, business turnarounds and M&A. Most recently, Mr. Hopkins served as the President and Chief Executive Officer of Professional Security Broadband Inc., where he was responsible for organically quadrupling revenue prior to being acquired by a private equity firm. John’s first public CFO appointment was at Measurement Specialties, a NASDAQ company, that is a leading global designer and manufacturer of sensors and sensor-based systems. Joining during a critical SEC investigation, he successfully led the financial restructuring efforts, returning the company to profitability and laying the groundwork for an eventual sale of the company for $1.7b (including assumption of net debt). After Measurement Specialties, Mr. Hopkins joined Henry Bros. Electronics, a NASDAQ company, as CFO where he was instrumental in a financial and operational turnaround, increasing the market cap by 130% prior to being acquired. Mr. Hopkins is a certified public accountant and holds an MBA from Villanova University and a bachelor’s degree in accounting from West Chester University. John volunteers teaching eighth graders as part of the Junior Achievement in the West Kensington section of Philadelphia. John also remains engaged competitively in rowing crew on boathouse row in Philadelphia.
お知らせ • Feb 13Tanke Biosciences Corp Appoints Vincent Renz as Chief Executive OfficerTanke Biosciences Corp. announced that Vincent Renz has been appointed Chief Executive Officer, effective February 9, 2025. Mr. Renz has over 30 years of leadership experience at C-Suite level, having served as CTO of eResearch Technology, CEO/COO of NewCardio, Inc, COO of Clinphone, Sr. Vice President, Client Services of Computron Software. Mr. Renz has served most recently as the President and Founder of Straight4ward Advisory Services. He is experienced with driving significant value creation for shareholders and delivering on both turnaround and growth strategies. In 2024, Renz joined Brand Craft Holdings in an advisory capacity to begin building the team to identify investment opportunities. Mr. Renz began his career with positions at Anderson Consulting and Deloitte focused on development and implementation of advanced technology solutions. He holds a BBA in Finance from the University of Notre Dame, as well as an MBA with a specialization in Information Technology from the Kelley School of Business at Indiana University.
お知らせ • Feb 12Tanke Biosciences Corp Announces Vincent Renz Joins its Board of DirectorsTanke Biosciences Corp. announced that Vincent Renz will join the Board of Directors, effective February 9, 2025. Mr. Renz has over 30 years of leadership experience at C-Suite level, having served as CTO of eResearch Technology, CEO/COO of NewCardio, Inc, COO of Clinphone, Sr. Vice President, Client Services of Computron Software. Mr. Renz has served most recently as the President and Founder of Straight4ward Advisory Services. He is experienced with driving significant value creation for shareholders and delivering on both turnaround and growth strategies. In 2024, Renz joined Brand Craft Holdings in an advisory capacity to begin building the team to identify investment opportunities. Mr. Renz began his career with positions at Anderson Consulting and Deloitte focused on development and implementation of advanced technology solutions. He holds a BBA in Finance from the University of Notre Dame, as well as an MBA with a specialization in Information Technology from the Kelley School of Business at Indiana University.
お知らせ • Feb 28Tanke Biosciences Corp Appoints Kenneth Marks to the Board of DirectorsTanke Biosciences Corp. d.b.a BrandCraft Holdings, LLC announced that Kenneth Marks has joined the board of directors. Mr. Marks has a strong record of accomplishment as a senior executive with a proven track record, providing excellent operating, financial and corporate development leadership in U.S. domestic and global markets. Mr. Marks has held senior level positions at Verizon Communications, Global Directory Services Company and Nynex Corporation as well as within the financial industry. At Verizon, Ken held the position of Vice President for Merger Integration following the merger between Bell Atlantic and GTE. Prior to Verizon, he was President and CEO of Global Directory Services Company, a Bell Atlantic and R.R.Donnelley &Sons joint venture. Ken managed the growth of the information services company from its inception to over $575 million in annual revenue and 2000 employees, operating from offices in Europe, Asia and North America. Ken Marks has worked with several private equity firms as a Senior Advisor, including, Fulcrum Funds, LLC and LKM Ventures, LLC. Responsibilities included sourcing of capital, evaluating business opportunities and directing due diligence activities.